Top Markets
Coin of the day
Microba Life Sciences Limited Microba Life Sciences Limited

Microba Life Sciences Limited

MAP
株式のランク #28063
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
株価
$0.04020123
時価総額
$28.83M
変化(1日)
0.00%
変化(1年)
-31.34%
AU
取引 Microba Life Sciences Limited (MAP)

カテゴリー

Microba Life Sciences Limited(MAP)の株式分割履歴
Microba Life Sciences Limited株(シンボル:MAP)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 20, 2026に行われました。
Aug 20, 2026より前に購入されたMAP株は、現在0MAP株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US